Wenjie Liu

2PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Apr 01, 2026
First-line versus second-line use of selpercatinib in treatment of RET fusion-positive advanced non-small cell lung cancer: a cost-effectiveness analysis.

Kai Wang, Wenjie Liu

|Feb 08, 2024
Cost-effectiveness of tisotumab vedotin as a second- or third-line therapy for cervical cancer.

Gengwei Huo, Wenjie Liu, Peng Chen

Pageof 1

Frequent Collaborators

1 joint publications

Gengwei Huo

1 joint publications

Peng Chen